Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist
about
Mechanisms involved in the development of chemotherapy-induced neuropathyRole of the haeme oxygenase/carbon monoxide pathway in mechanical nociceptor hypersensitivityNanoparticle fullerol alleviates radiculopathy via NLRP3 inflammasome and neuropeptides.Bilateral changes of TNF-alpha and IL-10 protein in the lumbar and cervical dorsal root ganglia following a unilateral chronic constriction injury of the sciatic nerveChronic musculoskeletal pain: review of mechanisms and biochemical biomarkers as assessed by the microdialysis techniqueIL-1β stimulates COX-2 dependent PGE₂ synthesis and CGRP release in rat trigeminal ganglia cells.Toll-like receptor 4 signaling contributes to Paclitaxel-induced peripheral neuropathy.Infection with Strongyloides venezuelensis induces transient airway eosinophilic inflammation, an increase in immunoglobulin E, and hyperresponsiveness in rats.Interleukin-1 receptor antagonist ameliorates neonatal lipopolysaccharide-induced long-lasting hyperalgesia in the adult ratsRole of the immune system in chronic pain.The critical role of leukotriene B4 in antigen-induced mechanical hyperalgesia in immunised rats.Effects of COX inhibition and LPS on formalin induced pain in the infant ratRecent advances in underlying pathologies provide insight into interleukin-8 expression-mediated inflammation and angiogenesis.Minocycline blocks lipopolysaccharide induced hyperalgesia by suppression of microglia but not astrocytes.Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists.Subclinical peripheral neuropathy is a common finding in colorectal cancer patients prior to chemotherapyEnhancement by interleukin-1β of AMPA and NMDA receptor-mediated currents in adult rat spinal superficial dorsal horn neurons.Brain cytokines as neuromodulators in cardiovascular control.Orofacial pain in cancer: part I--mechanisms.Peripheral mechanisms of pain and analgesia.The role of enhanced cutaneous IL-1beta signaling in a rat tibia fracture model of complex regional pain syndrome.Role of substance P signaling in enhanced nociceptive sensitization and local cytokine production after incision.Role of interleukin-1beta during pain and inflammation.Toll like receptor (TLR)-4 as a regulator of peripheral endogenous opioid-mediated analgesia in inflammation.Recent patents on novel P2X(7) receptor antagonists and their potential for reducing central nervous system inflammation.Lifetime Modulation of the Pain System via Neuroimmune and Neuroendocrine Interactions.IL-4, JAK-STAT signaling, and pain.A neuroinflammatory model for acute fatigue during exercise.TNF-α and sTNF-RII Are Associated with Pain Following Hip Fracture Surgery in Older Adults.In vivo and In vitro Anti-Inflammatory Activity of Indazole and Its Derivatives.Contribution of Pro-inflammatory Cytokine Signaling within Midbrain Periaqueductal Gray to Pain Sensitivity in Parkinson's Disease via GABAergic Pathway.Endogenous interleukin-10 is required for the defervescence of fever evoked by local lipopolysaccharide-induced and Staphylococcus aureus-induced inflammation in rats.Role of endogenous interleukin-1 receptor antagonist in regulating fever induced by localised inflammation in the rat.Articular inflammation induced by an enzymatically-inactive Lys49 phospholipase A2: activation of endogenous phospholipases contributes to the pronociceptive effectInhibition of fatty acid amide hydrolase produces PPAR-alpha-mediated analgesia in a rat model of inflammatory pain.Antihypernociceptive activity of anethole in experimental inflammatory pain.Cellular events during arthritis-induced hyperalgesia are mediated by interleukin-6 and p38 MAPK and their effects on the expression of spinal mu-opioid receptors.An electronic pressure-meter nociception paw test for rats.Streptozotocin-induced mechanical hypernociception is not dependent on hyperglycemia.Chronic ghrelin treatment reduced photophobia and anxiety-like behaviors in nitroglycerin- induced migraine: role of pituitary adenylate cyclase-activating polypeptide.
P2860
Q26824380-50B73FC8-C44E-4D8A-9864-7C222CCBFAAEQ28363017-6EFE91B6-0B23-4048-9B24-82C326612EBCQ30252648-409C615B-12A2-4169-8F42-61119A17DD65Q33687631-04E92C70-7425-4CAB-BCE7-8E3C433E31CFQ33774088-75B6ABD7-6436-4FDC-85B8-5426C78137CDQ33843307-21362998-D267-49B2-91F3-F4721DAAA386Q33851825-AF9E8612-9712-4772-BD4F-B3B92D4D8C86Q34181452-57FEB12E-B597-45EF-85BA-F63147FF6744Q34414263-28C5A5BE-E131-4BEE-9BAF-9A02748F4BDAQ34431134-65DDFFD9-73DD-4B3B-BD5C-7A083D3ED3C2Q35045518-B4C8D0D4-E242-47C2-B14C-8F26919CCCA3Q35185830-0583517F-25AF-466D-ABE6-0517405C4595Q35659991-7ECE8747-14EE-440F-8CF5-1D7BB0716F98Q36179484-5781CCA4-F2FC-453E-9154-43E86AB85CAFQ36558056-77B7F0B7-8C67-4888-BA43-06DC5BE8705CQ36748075-548EB6AF-104D-4AB7-89D3-7D7BA15062CBQ36755430-9C677E3C-410B-4A36-A29C-9C14F761A807Q36810335-8FA8B638-D389-4CEE-8B06-313ED90437D2Q36831523-D524401C-4D65-4231-9488-C0948CC75B77Q37314270-9B6A209C-2619-4E66-9137-FA398D6468A3Q37345168-AE9C4533-F645-42A0-A81C-0BCF913F62C6Q37351925-1865B525-4A6D-403F-AE26-2BB091A97442Q37376506-6D217E7B-329B-4C7B-8443-D30CA5F29B4FQ37581265-59264E2D-F55F-4EDB-91CC-A367F92DEC13Q37586481-ABA9706E-F47F-4C41-B998-BE96BC2A8B49Q37695333-B303FA75-3905-4F2C-9232-96478BB997EFQ38182594-08AFCD21-259A-4DE1-8AA4-6B7CB8C86DCAQ38244047-B9009822-7C0B-4848-93E8-86D3F6C028B5Q38689020-247260CC-B4D6-4A54-827C-0BF170B38F94Q39165034-CC9C249B-D06E-4FCF-A80E-62729C7E0724Q39509256-E1BDDFF5-EEDD-4490-B4A6-5BA9B2DE1795Q40561394-726B2CAC-FD9D-4232-80AC-F40A5C920F98Q40608792-E5312E87-FF2F-416A-B719-5E24773B1EB8Q41974570-2570B208-16A9-4457-9545-9EA1B81CE92AQ42248322-F3446A43-41A5-4439-8A62-3B89B0D8778BQ44302560-77F4FD8F-6879-4C7A-857D-64DC1C471A49Q44338466-D5622302-3751-4E36-9AAE-DC2D0A65352BQ44827445-B9B7AB06-5D82-4E56-8897-2CE762AEE116Q46093986-4D24DF24-CB51-4581-9FDA-04813F0E6928Q47368947-0D4712D7-9B5B-440D-A0A2-23E76F7FDBEC
P2860
Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist
description
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2000
@ast
im Juli 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2000/07/01)
@sk
vědecký článek publikovaný v roce 2000
@cs
wetenschappelijk artikel (gepubliceerd op 2000/07/01)
@nl
наукова стаття, опублікована в липні 2000
@uk
مقالة علمية (نشرت في يوليو 2000)
@ar
name
Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist
@ast
Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist
@en
Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist
@nl
type
label
Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist
@ast
Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist
@en
Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist
@nl
prefLabel
Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist
@ast
Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist
@en
Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist
@nl
P2093
P2860
P3181
P356
P1476
Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist
@en
P2093
F. Q. Cunha
J. M. Cunha
S. H. Ferreira
P2860
P304
P3181
P356
10.1038/SJ.BJP.0703434
P407
P577
2000-07-01T00:00:00Z